Register entry
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 6
- Labeller names
- 2
- Live patents
- 32
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human prescription drug. By marketing category: NDA 3, NDA AUTHORIZED GENERIC 3.
| Dosage form | NDCs |
|---|---|
| tablet | 5 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 6 |
| Labeller name on the listing | NDCs |
|---|---|
| currax pharmaceuticals llc | 3 |
| currax pharmaceuticals llc dba cypress, hawthorn, macoven | 3 |
Exclusivity
Patents and exclusivities
32| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10238620 | SILENORdoxepin hydrochloride | use | May 2027 |
| 10653662 | SILENORdoxepin hydrochloride | use | May 2027 |
| 12083090 | SILENORdoxepin hydrochloride | use | May 2027 |
| 9486437 | SILENORdoxepin hydrochloride | use | May 2027 |
| 9861607 | SILENORdoxepin hydrochloride | use | May 2027 |
| 10653660 | SILENORdoxepin hydrochloride | use | Jul 2027 |
| 11110074 | SILENORdoxepin hydrochloride | use | Jul 2027 |
| 9572814 | SILENORdoxepin hydrochloride | use | Jul 2027 |
| 7915307 | SILENORdoxepin hydrochloride | use | Aug 2027 |
| 11234954 | SILENORdoxepin hydrochloride | use | Jan 2028 |
| 10548871 | SILENORdoxepin hydrochloride | use | Apr 2028 |
| 11096920 | SILENORdoxepin hydrochloride | use | Apr 2028 |
| 9907780 | SILENORdoxepin hydrochloride | product | Apr 2028 |
| 9107898 | SILENORdoxepin hydrochloride | use | May 2028 |
| 9532971 | SILENORdoxepin hydrochloride | product | Jun 2029 |
| 8513299 | SILENORdoxepin hydrochloride | use | Sept 2030 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Silenor | doxepin hydrochloride | tablet, oral | 42847-103NDA |
| Silenor | doxepin hydrochloride | tablet, oral | 42847-106NDA |
| Sumatriptan Succinate and Naproxen Sodium | sumatriptan succinate and naproxen sodium | tablet, oral | 44183-850NDA AUTHORIZED GENERIC |
| Treximet | Sumatriptan Succinate and Naproxen Sodium | tablet, film coated, oral | 42847-850NDA |
| doxepin hydrochloride | doxepin hydrochloride | tablet, oral | 44183-103NDA AUTHORIZED GENERIC |
| doxepin hydrochloride | doxepin hydrochloride | tablet, oral | 44183-106NDA AUTHORIZED GENERIC |
Compare
Other companies listing doxepin hydrochloride
- Patheon Manufacturing Services LLC19 sites · 319 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Strides Pharma Science Limited5 sites · 230 NDC
- Safecor Health, LLC3 sites · 103 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- PD-Rx Pharmaceuticals Inc.1 site · 828 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Boswell Pharmacy Services LLC1 site · 15 NDC
Enquiry
Common questions
- Is Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven FDA approved?
- Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven make?
- 6 products are listed under Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven in the openFDA NDC Directory, most often as tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.